Friday, April 29, 2016

FDA Approves Two Supplemental Indications for Harvoni in Chronic Hepatitis C Patients With Advanced Liver Disease

›
In continuation of my update on  Harvoni (ledipasvir/sofosbuvir) Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S...
Thursday, April 28, 2016

Arbor Pharmaceuticals Announces FDA Approval of Cetylev

›
Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for Cetylev...
Wednesday, April 27, 2016

Study finds no beneficial effect of cancer medication on Alzheimer's disease

›
Bexarotene  (brand name:  Targretin ) is an  antineoplastic  (anti-cancer) agent approved by the  U.S. Food and Drug Administration  (FD...
Tuesday, April 26, 2016

Impax Receives Approval of Emverm (mebendazole) Chewable Tablets

›
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the United States Food and Drug Administration (FDA) has approved the Company...
Monday, April 25, 2016

Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for Dalvance (dalbavancin)

›
In continuation of my update on Dalbavancin Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the...
Thursday, April 21, 2016

Adzenys XR-ODT (amphetamine) FDA Approval History

›
Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product can...

FDA Approves Halaven (eribulin mesylate) for the Treatment of Liposarcoma

›
The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposar...
Wednesday, April 20, 2016

FDA Approves Onzetra Xsail (sumatriptan nasal powder) for the Acute Treatment of Migraine

›
Sumatriptan is a medication used for the treatment of migraine headaches. It is a synthetic drug belonging to the   triptan   class. ...
Tuesday, April 19, 2016

FDA Approves Takeda's Dexilant SoluTab (dexlansoprazole)

›
Dexlansoprazole  ( INN , trade names  Kapidex ,  Dexilant ) is a  proton pump inhibitor  that is marketed by  Takeda Pharmaceuticals  fo...
Monday, April 18, 2016

Promius Pharma Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray

›
We know that Betamethasone dipropionate (see structure)  is a glucocorticoid steroid with anti-inflammatory and immunosuppressive abi...
Friday, April 15, 2016

FDA Approves Expanded Use of Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C

›
In continuation  of my update on Daclatasvir Bristol-Myers Squibb Company (NYSE:BMY) announced today that Daklinza (daclatasvir,...
Thursday, April 14, 2016

Ambrisentan avoids sildenafil drug interaction in PAH patients

›
Sildenafil may be better given to pulmonary arterial hypertension patients in combination with ambrisentan than with bosentan, study findi...
Tuesday, April 12, 2016

Positive data on ability of MyoKardia’s MYK-461 to prevent development of HCM

›
Positive data on ability of MyoKardia’s MYK-461 to prevent development of HCM   MyoKardia, Inc., a clinical stage biopharmaceutical co...
Monday, April 11, 2016

Bosutinib shows 'low' vascular, cardiac event risk profile

›
 In continuation of my update on  Bosutinib Third-generation tyrosine kinase inhibitor (TKI) study findings suggest that bosutinib i...

EC approves expanded use of Daklinza (daclatasvir) for patients with chronic HCV and HIV co-infection

›
Daclatasvir  formerly  BMS-790052 , trade name  Daklinza ) is a drug for the treatment of hepatitis C (HCV). It was developed by Bri...